Organic Letters
Letter
2010, 75, 5768. (c) Chen, D.; Bao, W.-L. Adv. Synth. Catal. 2010, 352,
955. (d) Li, Z.-S.; Wang, W.-X.; Yang, J.-D.; Wu, Y.-W.; Zhang, W.
Org. Lett. 2013, 15, 3820. (e) Gao, P.; Gu, Y.-R.; Duan, X.-H. Synthesis
2017, 49, 3407.
Scheme 5. Proposed Mechanism
(3) (a) Nikam, S. S.; Sahasrabudhe, A. D.; Shastri, R. K.;
Ramanathan, S. Synthesis 1983, 1983, 145. (b) Lawrence, D. S.;
Copper, J. E.; Smith, C. D. J. Med. Chem. 2001, 44, 594. (c) Udilova,
N.; Kozlov, A. V.; Bieberschulte, W.; Frei, K.; Ehrenberger, K.; Nohl,
H. Biochem. Pharmacol. 2003, 65, 59. (d) Qin, X.; Hao, X.; Han, H.;
Zhu, S.; Yang, Y.; Wu, B.; Hussain, S.; Parveen, S.; Jing, C.; Ma, B.;
Zhu, C. J. Med. Chem. 2015, 58, 1254. (e) Han, Y.-Y.; Wu, Z.-J.;
Zhang, X.-M.; Yuan, W.-C. Tetrahedron Lett. 2010, 51, 2023. (f) Carrer,
̈
A.; Brion, J. D.; Messaoudi, S.; Alami, M. Org. Lett. 2013, 15, 5606.
(g) Yin, K.; Zhang, R.-H. Org. Lett. 2017, 19, 1530. (h) Paul, S.; Ha, J.
H.; Park, G. E.; Lee, Y. R. Adv. Synth. Catal. 2017, 359, 1515. (i) Yuan,
J.-W.; Liu, S.-N.; Qu, L.-B. Adv. Synth. Catal. 2017, 359, 4197. (j) Gao,
M.; Li, Y.; Xie, L.-J.; Chauvin, R.; Cui, X.-L. Chem. Commun. 2016, 52,
2846. (k) Li, Y.; Gao, M.; Wang, L.-H.; Cui, X.-L. Org. Biomol. Chem.
2016, 14, 8428. (l) Gupta, A.; Deshmukh, M. S.; Jain, N. J. Org. Chem.
2017, 82, 4784. (m) Zeng, X.-B.; Liu, C.-L.; Wang, X.-Y.; Zhang, J.-L.;
Wang, X.-Y.; Hu, Y.- F. Org. Biomol. Chem. 2017, 15, 8929.
(4) (a) Fleming, F. F. Nat. Prod. Rep. 1999, 16, 597. (b) May, E. L.;
Jacobson, A. E.; Mattson, M. V.; Traynor, J. R.; Woods, J. H.; Harris,
L. S.; Bowman, E. R.; Aceto, M. D. J. Med. Chem. 2000, 43, 5030.
(c) Fleming, F. F.; Yao, L.; Ravikumar, P. C.; Funk, L.; Shook, B. C. J.
Med. Chem. 2010, 53, 7902.
In summary, we have developed an efficient Fe-catalyzed
cyanoalkylation reaction of quinoxalin-2(1H)-ones with cyclo-
butanone oxime esters. This reaction features wide substrate
scope, excellent functional group tolerance, and good to
excellent yields, thus providing facile and useful access to a
variety of 3-cyanoalkylated quinoxalin-2(1H)-ones. Besides
cyclobutanone oxime esters, the cyclopentanone and cyclo-
hexanone derivatives were also applicable to this reaction. This
protocol offers a new and promising family of direct C−H
functionalizations of heteroarenes based on a C−C bond
cleavage process. Preliminary mechanistic evidence suggests
that the cyanoalkylation reaction proceeds via a radical
pathway.
(5) For reviews, see: (a) Fleming, F. F.; Zhang, Z.-Y. Tetrahedron
2005, 61, 747. (b) Lop
54, 13170.
́
ez, R.; Palomo, C. Angew. Chem., Int. Ed. 2015,
ASSOCIATED CONTENT
* Supporting Information
■
(6) For selected examples, see: (a) Li, Z.-J.; Xiao, Y.-X.; Liu, Z.-Q.
Chem. Commun. 2015, 51, 9969. (b) Bunescu, A.; Wang, Q.; Zhu, J.
Angew. Chem., Int. Ed. 2015, 54, 3132. (c) Chatalova-Sazepin, C.;
Wang, Q.; Sammis, G. M.; Zhu, J. Angew. Chem., Int. Ed. 2015, 54,
5443. (d) Bunescu, A.; Wang, Q.; Zhu, J. Org. Lett. 2015, 17, 1890.
(e) Ha, T. M.; Chatalova-Sazepin, C.; Wang, Q.; Zhu, J. Angew. Chem.,
Int. Ed. 2016, 55, 9249. (f) Chu, X.-Q.; Xing, Z.-H.; Meng, H.; Xu, X.-
P.; Ji, S.-J. Org. Chem. Front. 2016, 3, 165. (g) Zhang, H.-L.; Zhu, C.-J.
Org. Chem. Front. 2017, 4, 1272. (h) Su, H.-M.; Wang, L.-Y.; Rao, H.-
H.; Xu, H. Org. Lett. 2017, 19, 2226.
(7) For examples concerning radical ring opening of cyclobutanone
oxime derivatives, see: (a) Boivin, J.; Fouquet, E.; Zard, S. Z. J. Am.
Chem. Soc. 1991, 113, 1055. (b) Boivin, J.; Fouquet, E.; Zard, S. Z.
Tetrahedron Lett. 1991, 32, 4299. (c) Nishimura, T.; Yoshinaka, T.;
Nishiguchi, Y.; Maeda, Y.; Uemura, S. Org. Lett. 2005, 7, 2425.
(d) Yang, H.-B.; Selander, N. Chem. - Eur. J. 2017, 23, 1779. (e) Zhao,
B.; Shi, Z. Angew. Chem., Int. Ed. 2017, 56, 12727. (f) Li, L.-Y.; Chen,
H.-G.; Mei, M.-J.; Zhou, L. Chem. Commun. 2017, 53, 11544.
(g) Yang, H.-B.; Pathipati, S. R.; Selander, N. ACS Catal. 2017, 7,
8441. (h) Dauncey, E. M.; Morcillo, S. P.; Douglas, J. J.; Sheikh, N. S.;
Leonori, D. Angew. Chem., Int. Ed. 2018, 57, 744. (i) Yu, X.-Y.; Chen,
J.-R.; Wang, P.-Z.; Yang, M.-N.; Liang, D.; Xiao, W.-J. Angew. Chem.,
Int. Ed. 2018, 57, 738. (j) Jackman, M. M.; Im, S.; Bohman, S. R.; Lo,
C. C. L.; Garrity, A. L.; Castle, S. L. Chem. - Eur. J. 2018, 24, 594.
(8) For palladium-catalyzed ring opening of cyclobutanone oxime
esters, see: (a) Nishimura, T.; Uemura, S. J. Am. Chem. Soc. 2000, 122,
12049. (b) Nishimura, T.; Nishiguchi, Y.; Maeda, Y.; Uemura, S. J. Org.
Chem. 2004, 69, 5342.
S
The Supporting Information is available free of charge on the
Experimental procedures and spectroscopic data for new
AUTHOR INFORMATION
■
Corresponding Author
ORCID
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
Financial support from the Natural Science Basic Research Plan
in Shaanxi Province of China (2016JZ002), the National
Natural Science Foundation of China (21602168), and the
Fundamental Research Funds of the Central Universities
(zrzd2017001, xjj2016056, and 1191329724) is greatly
appreciated.
(9) (a) Gu, Y.-R.; Duan, X.-H.; Yang, L.; Guo, L.-N. Org. Lett. 2017,
19, 5908. (b) Wu, J.; Zhang, J.-Y.; Gao, P.; Xu, S.-L.; Guo, L.-N. J. Org.
Chem. 2018, 83, 1046.
REFERENCES
■
(1) (a) Ries, U. J.; Priepke, H. W. M.; Hauel, N. H.; Handschuh, S.;
Mihm, G.; Stassen, J. M.; Wienen, W.; Nar, H. Bioorg. Med. Chem. Lett.
2003, 13, 2297. (b) Carta, A.; Piras, S.; Loriga, G.; Paglietti, G. Mini-
Rev. Med. Chem. 2006, 6, 1179. (c) Li, X.; Yang, K.; Li, W.; Xu, W.
Drugs Future 2006, 31, 979. (d) Liu, R.; Huang, Z.-H.; Murray, M. G.;
Guo, X.-Y.; Liu, G. J. Med. Chem. 2011, 54, 5747. (e) Hussain, S.;
Parveen, S.; Hao, X.; Zhang, S.-Z.; Wang, W.; Qin, X.-Y.; Yang, Y.-C.;
Chen, X.; Zhu, S.-J.; Zhu, C.-J.; Ma, B. Eur. J. Med. Chem. 2014, 80,
383.
(2) (a) Mamedov, V. A.; Zhukova, N. A. Prog. Heterocycl. Chem.
2012, 24, 55. (b) Chen, D.; Wang, Z.-J.; Bao, W.-L. J. Org. Chem.
D
Org. Lett. XXXX, XXX, XXX−XXX